S. 2895 · 116th Congress
SARMs Control Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
GrassleySponsor1 cosponsor · 1 D
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Selective Androgen Receptor Modulators Control Act of 2019 or the SARMs Control Act of 2019
What it does: CRS summary · Introduced in Senate · Nov 19, 2019
Selective Androgen Receptor Modulators Control Act of 2019 or the SARMs Control Act of 2019
This bill expands the federal regulatory framework for drugs that are deemed to pose a risk of abuse and dependence to address selective androgen receptor modulators. These are synthetic drugs or substances that have effects similar to testosterone.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: SARMs Control Act of 2019
Also known as: Selective Androgen Receptor Modulators Control Act of 2019
Latest action (Nov 19, 2019): Read twice and referred to the Committee on the Judiciary.
Policy area: Crime and Law Enforcement · Origin: Senate · Introduced: Nov 19, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.